National Research Overview
National Research (NRC) has a P/E ratio of 77.49, above the Healthcare sector average of 26.36.
Get informed when a big investor buys or sells
+ Follow77.49
The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.
As of the most recent data, NRC shows a P/E ratio of 77.49. That is above the Healthcare sector average of 26.36. Scroll down for historical charts and peer comparison views.
The Healthcare sector average P/E ratio is about 26.36. National Research is at 77.49, which is higher that average. That is roughly 194.0% above the sector mean. Use the comparison chart on this page to see how NRC stacks up against individual peers as well.
Investors watch NRC's P/E ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. National Research's latest reading is 77.49. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this p/e ratio page, Stockcircle has National Research's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect P/E ratio (currently 77.49) with ownership activity and broader fundamentals.
The Healthcare average P/E ratio is about 26.36, while NRC is at 77.49. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
